Paving the Way Toward Meaningful Trials in Ataxias: An Ataxia Global Initiative Perspective

Affiliations

• ¹ German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
• ² Department of Neurology, University Hospital Bonn, Bonn, Germany.
• ³ Houston Methodist Research Institute and Weil Cornell Medical College at Houston Methodist, Houston, Texas, USA.
• ⁴ McGill University, Montreal, Quebec, Canada.
• ⁵ Biogen, Cambridge, Massachusetts, USA.
• ⁶ Sorbonne Université, Paris Brain Institute, Paris Brain Institute - ICM, INSERM, CNRS, APHP, University Hospital de la Pitié-Salpêtrière Paris, Paris, France.
• ⁷ Departments of Neurology and Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
• ⁸ Ataxia UK, London, United Kingdom.
• ⁹ National Ataxia Foundation, Minneapolis, Minnesota, USA.
• ¹⁰ Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.
• ¹¹ Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
• ¹² Xiangya Hospital, Central South University, Changsha, China.
• ¹³ Brain Research Institute, Niigata University, Niigata, Japan.
• ¹⁴ Ataxia Unit, Department of Neurology, Universidade Federal de São Paulo, São Paulo, Brazil.
• ¹⁵ National Yang-Ming Chiao Tung University, Taipei, Taiwan.
• ¹⁶ Taipei Neurologic Institute, Taipei Medical University, Taipei, Taiwan.
• ¹⁷ University of Melbourne, Parkville, Victoria, Australia.
• ¹⁸ Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
• ¹⁹ Center for Rare Diseases, University Hospital Tübingen, Tübingen, Germany.
• ²⁰ Division Translational Genomics of Neurodegenerative Diseases, Center for Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
• ²¹ German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.